BlackRock has announced the upcoming liquidation of several U.S.-domiciled mutual funds and ETFs, including the BlackRock Health Sciences Trust, as part of its ongoing assessment to meet investors' evolving needs. The liquidation process involves 14 funds in total, with specific liquidation dates provided for each. Investors in these funds will continue to incur management fees until the liquidations are finalized, and those opting to sell their ETFs will also bear transaction and commission costs. This move is part of BlackRock's broader strategy to align its investment offerings with client objectives, leveraging its expansive platform to manage over $1 trillion in sustainable and transition investing assets globally.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。